EcoDrugPlus

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSEEUG00000000824
Gene Symbol: PDGFRA
1 External references
204 Possible Orthologues:

Platelet Derived Growth Factor Subunit B

Ensembl ID : ENSEEUG00000000707
Gene Symbol: PDGFB
1 External references
263 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 1

Ensembl ID : ENSEEUG00000012253
Gene Symbol: PARP1
1 External references
207 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 2

Ensembl ID : ENSEEUG00000012056
Gene Symbol: PARP2
1 External references
186 Possible Orthologues:

Poly(Adp-Ribose) Polymerase Family Member 3

Ensembl ID : ENSEEUG00000000696
Gene Symbol: PARP3
1 External references
200 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSEEUG00000005279
Gene Symbol: PORCN
1 External references
266 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily M Alpha 1

Ensembl ID : ENSEEUG00000015314
Gene Symbol: KCNMA1
1 External references
297 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 11

Ensembl ID : ENSEEUG00000013033
Gene Symbol: KCNJ11
1 External references
190 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 2

Ensembl ID : ENSEEUG00000006862
Gene Symbol: KCNJ2
4 External references
273 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 3

Ensembl ID : ENSEEUG00000010677
Gene Symbol: KCNJ3
1 External references
229 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 5

Ensembl ID : ENSEEUG00000005570
Gene Symbol: KCNJ5
4 External references
213 Possible Orthologues:

Potassium Two Pore Domain Channel Subfamily K Member 2

Ensembl ID : ENSEEUG00000010811
Gene Symbol: KCNK2
1 External references
284 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).